CAN IMMUNOME BOUNCE BACK FROM CLINICAL HOLD ON IMM-BCP-01

$IMNM   Immunome, Inc. (NASDAQ: IMNM), a biopharmaceutical company, announced the receipt of a clinical hold letter from the U.S. Food and Drug Administration (FDA) for its recently submitted...read more